Paul Hagopian, Brand Insights Contributor, Head of Fingerpaint’s Bay Area office
Advertisement
Articles by Paul Hagopian, Brand Insights Contributor, Head of Fingerpaint’s Bay Area office
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
CagriSema Tops Eli Lilly's Tirzepatide for Weight Loss in Late-Stage Diabetes Trial: Report
2
Pharmaceutical Executive Daily: AbbVie Forms Ai-Powered Drug Discovery Partnership with Iambic
3
Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset
4
Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM
5